PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15893609-0	2005	A role of IL-1 in MPTP-induced changes in striatal dopaminergic and serotoninergic transporter binding: clues from interleukin-1 type I receptor-deficient mice.	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	18-22	interleukin 1 complex	Mus musculus	10-14	
15862160-9	2005	Plasma IL-1 levels also increased on day 3 after last time injection of MPTP, and the level of left pawed mice was higher than that of right pawed mice.	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	72-76	interleukin 1 complex	Mus musculus	7-11	
15862160-0	2005	[Kinetic changes of plasma IL-1 and IL-6 levels in MPTP-induced Parkinson"s disease model mice and their relationship with brain asymmetry].	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	51-55	interleukin 1 complex	Mus musculus	27-31	
15862160-10	2005	CONCLUSION: IL-6 and IL-1 probably participate in the occurrence and progress of MPTP-induced PD in model mice, and were related with brain asymmetry.	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	81-85	interleukin 1 complex	Mus musculus	21-25	
9671653-4	1998	We found that interleukin-1 (IL-1), an immune response-generated cytokine that can enhance dopaminergic sprouting when exogenously applied, increased dramatically in the denervated striatum of young mice (2 months) compared with middle-aged mice (8 months) after MPTP treatment.	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	263-267	interleukin 1 complex	Mus musculus	14-27	
9671653-4	1998	We found that interleukin-1 (IL-1), an immune response-generated cytokine that can enhance dopaminergic sprouting when exogenously applied, increased dramatically in the denervated striatum of young mice (2 months) compared with middle-aged mice (8 months) after MPTP treatment.	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	263-267	interleukin 1 complex	Mus musculus	29-33	
17592750-6	2007	MPTP-induced microgliosis in striatum and olfactory bulb was reduced in IL-1alpha/beta knockout mice, indicating that IL-1 affects microglia activation.	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	0-4	interleukin 1 complex	Mus musculus	72-76	
17592750-7	2007	Importantly, MPTP induced differential regulation of IL-1 receptors.	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	13-17	interleukin 1 complex	Mus musculus	53-57	
17592750-10	2007	We suggest that differential regulation of IL-1 signaling can serve as an important mechanism to modulate neuroinflammatory activity after MPTP treatment and possibly during PD.	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	139-143	interleukin 1 complex	Mus musculus	43-47